News Quantified

CNSP – cns pharmaceuticals, inc. (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

CNS Pharmaceuticals, Inc. (CNSP) Shareholder/Analyst Call Prepared Remarks Transcript [Seeking Alpha]

CNS Pharmaceuticals Reports Third Quarter 2025 Financial Results and Provides Corporate Update [Yahoo! Finance]

CNS Pharmaceuticals (NASDAQ:CNSP) was upgraded by analysts at Maxim Group from a "hold" rating to a "buy" rating. They now have a $20.00 price target on the stock.

Form 8-K CNS Pharmaceuticals, For: Nov 17

Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Keyes Jeffry R.

Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Mahery Amy

Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Downs Christopher

Form 4 CNS Pharmaceuticals, For: Nov 17 Filed by: Climaco John M

Top News Gainers

4/9 WPD Pharmaceuticals Reports Active Compound in Licensed Drug Candidate Reduces Coronavirus Replication in Vitro by 100% 18.0%

11/8 Form EFFECT CNS Pharmaceuticals, 11.2%

11/21 CNS Pharmaceuticals Filed Request with FDA for Pre-IND Meeting for Berubicin 10.6%

3/24 WPD Pharmaceuticals Partners with CNS Pharmaceuticals on Drug Development for Coronavirus and Other Antiviral Indications 7.1%

2/4 CNS Pharmaceuticals Announces Completion of GMP Manufacturing 5.5%

4/24 Form C-TR CNS Pharmaceuticals, 5.0%

11/19 CNS Pharmaceuticals Acquired Worldwide Rights for Brain Cancer Drug from Houston Pharmaceuticals 4.1%

11/13 CNS Pharmaceuticals Announces Closing Of Initial Public Offering of Common Stock 3.9%

3/2 Form 8-K CNS Pharmaceuticals, For: Mar 02 3.1%

2/27 CNS Pharmaceuticals to Ring Nasdaq Stock Market Opening Bell on March 3 2.9%

Top News Decliners

3/23 Biotechs and Big Pharma in a Race Against Time Battling Global Health Crisis -31.4%

3/13 WPD PHARMACEUTICALS ANNOUNCES BRAIN CANCER PATIENT FROM BERUBICIN PHASE 1 TRIAL REMAINS CANCER FREE [Canadian Business Journal (Canada)] -25.3%

3/24 CNS Pharma up 46% premarket on potential coronavirus candidates [Seeking Alpha] -22.4%

4/9 CNS Pharma up 19% premarket on development of COVID-19 candidates [Seeking Alpha] -20.8%

3/10 Form 8-K CNS Pharmaceuticals, For: Mar 10 -17.5%

4/23 Orphan Drug Act Fueling $200 Billion Dollar Market -15.7%

3/3 Prognosis for Treatment of Glioblastoma Multiforme Expected to Impact Market Growth for Drug Makers -15.0%

12/10 Small Molecule Oncology Drug Market Forecast to Exceed $66 Billion in 2019 -14.1%

1/14 Global Brain Tumor Drugs Market Expected to Exceed $3 Billion Through 2022 -12.6%

4/21 WPD Pharmaceuticals and CNS Pharmaceuticals Announce Additional Coronavirus Testing on WP1122 by ImQuest Biosciences -12.3%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day